In this CE activity, expert faculty review abstract data from EURetina and AAO regarding new therapeutic protocols and the latest information on safety and efficacy of anti-VEGF therapies used in the treatment of nAMD and DME.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://www.healio.com/cme/ophthalmology/20241205/3-icym-evolving-management-protocols-for-retinal-diseases/overview
- Start Date: 2024-12-15 06:00:00
- End Date: 2024-12-15 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.5 hours
- Commercial Support: Source: Regeneron Pharmaceuticals, Inc. - Amount: 98510.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest